Robert A. Lustig, M.D.
Clinical Associate Professor of Radiation Oncology
Education
- B.A. Franklin & Marshall College (Biology) Lancaster, PA 1962-1965
- M.D. Jefferson Medical College, Philadelphia, PA 1965-1969
- Intern in Medicine, Metropolitan Hospital, New York 1969-1970
- Resident Medicine Metropolitan Hospital, New York 1970-1973
- Resident Radiaiton Oncology, Thomas Jefferson University Hospital Philadelphia, PA 1973-1976
Board Certifications
- American Board of Radiology, Radiation Oncology, 1976
Areas of Interest
My areas of clinical interests include adult and pediatric brain tumors, head and neck cancers, and photodynamic therapy. Specific areas of research interests are local therapies for glioblastoma including implants, radio-labelled antibodies, radiation sensitizers, photodynamic research in skin cancers, head and neck cancers, and metastatic liver cancers.
Publications
Lustig, R., Lowe, N., Prosnitz, L., Spaulding, M., Cohen, M., Stitt, J., and Brannon, R., Fluosol and Oxygen Breathing as an Adjuvant to Radiation Therapy in the Treatment of Locally Advanced Non-Small Cell Carcinoma of the Lung: Results of a Phase I/II Study. Int. J. Rad. Oncol. Biol. Phys., Vol 19, 97-102, July 1990.
Lustig, R.A., Krall, J.M., Curran, W.J., and Hanks, G.E.; Improvements Observed in Care and Outcome in Carcinoma of the Larynx. Int. J. Rad. Oncol. Biol. Phys., Vol 20, 101-104, January 1991.
A. Dimofte, MSA, Timothy C. Zhu PhD, Stephen Hahn, MD Robert A. Lustig, MD In-vivo Light Dosimetry for Motexifen Lutetium-mediated PDT of Recurrent Breast Cancer. Lasers in Surgery and Medicine 31:305-312 2002.
Timothy C. Zhu, Andreea Dimofte, Stephen M. Hahn, and Robert A. Lustig Light Dosimetry at Tissue Surfaces for Small Circular Fields. Proc. of SPIE Vol. 4952: 56-67 (2003)
Lustig RA, Vogl TJ Fromm D, CuencaR, HsiRA, D’Cruz AK, Krajina Z, Turic M, Singhal A, Chen JC A Multicenter Phase I Safety Study of Intratumoral Photoactivation of Talaporfin Sodium in Patients with Refractory Solid Tumors. Cancer Vol 98, #8 Jul. (1767-1771), 2003.
Lustig R, Scott C, Curran W. Does Stereotactic Eligibility for the Treatment of Glioblastomas Cause Selection Bias in Randomized Studies. Amer.J.Clin.Oncol. Am. J. of Clinc. Onc. Vol 27, No. 5, p.1-6, Oct. 2004
Metz, J.m., Smith, D., Mick, R., Lustig, R., Mitchell, J., Cherakuri, M., Glatstein, E., and Hahn, S. A Phase 1 Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy. Clin. CA. Research, 2004
Maity, A, Shu, H-K, Tan, J, Ruffer, J, Sutton, L, Tochner, Z, and Lustig, R. Treatment of pediatric intracranial arteriovenous malformations with linear accelerator based stereotactic radiosurgery: the University of Pennsylvania experience. Ped Neurosurg, Vol. 40, No. 5, pp 207-214, 2004.
Lustig, R., Mikkelsen, T., Olson, J., Rogers, L., Sanan, A., and Tatter, S. Appropriate Selection of Brain Tumor Patient for Treatment with the GliaSite Radiation Therapy System 2004.
Armstrong, C.L., Kunsang, G., Awadalla, A., Lustig, R., Tochner, Z. A Critical review of the Effects of Therapeutic Irradiation on Brain: The Roots of Controversy. Neurophychology Review, Vol. 14, No. 1, March, 2004.
» TOP
© University of Pennsylvania | School of Medicine | University of Pennsylvania Health System